GRI Bio, Inc.
GRI
$0.20
$0.012.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.15% | 5.06% | -56.37% | 8.20% | 5.69% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 100.97% | -10,400.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 801.89% | -77.06% | 13.79% | 331.91% | 144.76% |
| Change in Net Operating Assets | 272.87% | -130.43% | 1,167.33% | 47.94% | -191.08% |
| Cash from Operations | 26.94% | -82.37% | 13.16% | 11.86% | -5.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.73% | -- | -- | 131.23% | -79.27% |
| Repurchase of Common Stock | -- | 100.00% | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 59.96% | -9,240.00% | 89.58% | 73.77% | 34.29% |
| Cash from Financing | -75.11% | 45,618.18% | -100.48% | 245.08% | -84.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.96% | 205.38% | -719.50% | 117.55% | -171.04% |